Equity
-€6,220
Debts exceed assets in financial year 2025.
POLYPHEMUS
Lifetime
2 annual accounts with figures on one time axispeak -€1,035 (2025)
-€1,035▲ €3,982
lowest -€5,593 (2024)
-€2,126▲ €3,467
peak -€4,093 (2024)
-€6,220▼ €2,126
€40,822▲ 3.5%
Board1 name since 2023
1 director
Documentsfilings and deeds
24-08-202624 days late
2025micro format
Gross margin from -€5,016 to -€1,035Loss of €2,126Equity from -€4,093 to -€6,220
Key points
from the 2025 annual accountsLosses
-€7,720 in two years
The 2024 and 2025 financial years closed with a loss. 2024 was the heaviest.
Debts
€40,822 118% of the balance sheet
2025 accounts filed 24 days after the deadlineTurnover not published (micro format)
Checked score
Bankruptcy probability within 12 months
Financial strength
Score breakdown
Comparable companies, two years later
In July 2024, 1,554 companies had the same profile as POLYPHEMUS has now. Each dot stands for 4 companies, two years later.
91.6%
were still trading
3.6%
stopped another way
4.6%
went bankrupt
Another 0.2% stopped without a precise date, possibly only after those two years.
Test of the method
The method was tested on the 497,331 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.
| Group | Expected | Actual |
|---|---|---|
| 1 | 0.2% | 0.2% |
| 2 | 0.3% | 0.5% |
| 3 | 0.5% | 0.6% |
| 4 | 0.7% | 0.8% |
| 5 | 0.9% | 0.9% |
| 6 | 1.3% | 1.5% |
| 7 | 1.6% | 1.8% |
| 8 | 1.8% | 1.8% |
| 9 | 2.9% | 3.1% |
| 10 | 5.6% | 6.1% |
A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.
This is an observation about 1,554 companies, not a prediction for POLYPHEMUS. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.
Credit verdict
Credit check for an amount and term of your choice
Show the recommended maximum and see how the verdict changes with amount, term and advance.
The scores and ratios are Checked's own calculations, not a credit decision.
Signals
Recent changes
Registered in the Peppol Directory
Reachable for e-invoices through 0208:1002645646
Incorporation
Founding capital of €1,500, 150 shares · Founder: (comparant et fondateur) · Appointment: (director) · published on 28-11-2023 · Gazette deed
First establishment
Hertogendreef 60, Watermael-Boitsfort
Comparable companies
same main activity, similar in size and age| Company | ||||
|---|---|---|---|---|
| POLYPHEMUS Watermael-Boitsfort | €34,603 | -€1,035 | -18.0% | - |
| NCD Consultants Overijse | €55,512 | -€15,605 | 13.9% | - |
| Benno Therapeutics Leuven | €56,724 | -€194,008 | -893.4% | - |
| OncoRNA Charleroi | €20,034 | -€15,237 | -159.0% | - |
| RheADC Leuven | €31,395 | -€116,226 | -364.3% | - |
| Sealantium Medical Belgium Diepenbeek | €56,033 | -€7,311 | 46.8% | - |
| OTRO FOODS Seraing | €18,469 | -€28,746 | -33.4% | - |
These companies have the same main activity as POLYPHEMUS: research and development on biotechnology (NACE 72101). They are comparable in size and age: total assets between €18,500 and €56,700, founded between 2023 and 2024.
Official details
Source: KBO- Status
- Active since 24-11-2023Normal situation
- Activity
- Research and development on biotechnologyNACE 72101and 3 others
- Establishment unit
- 2.352.381.0481170 Watermael-Boitsfort, since 24-11-2023
- Financial year end
- 31 December
- Peppol
- Reachable since 22-09-2026
Insights on POLYPHEMUS
POLYPHEMUS has been active since 2023 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show negative equity (-€6,220) and a net result of -€2,126.
Its solvency ranks better than 11% of 666 sector peers (NACE 72, financial year 2025).
Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.
Key facts about POLYPHEMUS
- What is the company number of POLYPHEMUS?
- The company number of POLYPHEMUS is 1002.645.646. The VAT number is the same number with BE in front: BE 1002.645.646.
- Where is POLYPHEMUS based?
- The registered office is at Hertogendreef 60, 1170 Watermael-Boitsfort.Company details
- What does POLYPHEMUS do?
- According to the KBO register, the main activity is research and development on biotechnology (NACE 72101).
- What is the legal form of POLYPHEMUS?
- POLYPHEMUS is a private limited company (BV).
- When was POLYPHEMUS founded?
- POLYPHEMUS was founded on 24-11-2023.
- Is POLYPHEMUS still active?
- Yes, POLYPHEMUS is an active enterprise in the KBO register.
- What is the turnover of POLYPHEMUS?
- The annual accounts for financial year 2025 state no turnover. The micro format does not require it.Financials
- Is POLYPHEMUS profitable?
- In financial year 2025, POLYPHEMUS made a loss of €2,126.
- Where can I find the annual accounts of POLYPHEMUS?
- POLYPHEMUS filed 2 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
- When are the next annual accounts of POLYPHEMUS due?
- POLYPHEMUS must file the annual accounts for financial year 2026 by 31-07-2027.Timeline
Next steps
Work out how much credit to give this customer and on what payment terms.Credit check Check what to know before you do business with this company.Supplier due diligence Check whether you can accept this company as a client under the anti-money-laundering law.AML client file Check which of your other customers you can e-invoice via Peppol.Peppol check Compare this company with its sector.Sector benchmark See what changed in the latest annual accounts.What changed
See how customers, suppliers and banks see your own company and what to improve first.